Temasek Holdings (Private) LTD Vaxcyte, Inc. Transaction History

Temasek Holdings (Private) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Apr 05, 2023	BUY	$21.69 - $28.53 $591,529 - $778,070	27,272 New	27,272 $655,000
Q1 2022 May 15, 2023	BUY	$17.46 - $26.36 $476,169 - $718,889	27,272 New	27,272 $658,000
Q3 2021 Nov 15, 2021	BUY	$20.26 - $26.97 $552,530 - $735,525	27,272 New	27,272 $692,000
Q2 2021 Aug 16, 2021	SELL	$16.45 - $24.06 $448,624 - $656,164	-27,272 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$18.66 - $29.16 $508,895 - $795,251	27,272 New	27,272 $539,000

357

123M

772K

430K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.24B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

Stay updated on Temasek Holdings (Private) LTD with notifications on news.